1Gene
Latest round
- Seed
Last raised
- Sep 2014
Total raised
- $0.8M
Investors
- 1
About 1Gene
com, Zhejiang Cancer Hospital, Illumina, etc. It qualified as a medical laboratory in January 2017. In April 2022, it passed the KRAS mutation interval quality assessment with a full score. The company's products can be categorized into bowel cancer early screening, stomach cancer early screening, gastrointestinal cancer early screening, fecal occult blood self-test, full set of tumor genetic susceptibility tests, and gastric cancer pathogenic bacteria screening and medication guidance.
Who invested in 1Gene
1 investor across 1 round
See all investors in 1Gene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 5, 2014
Amount
$0.8M
Investors
Questions about 1Gene
Who invested in 1Gene?
1Gene has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 1Gene raised?
1Gene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did 1Gene last raise money?
1Gene's most recent round on record is a Seed, in Sep 2014.
What does 1Gene do?
com, Zhejiang Cancer Hospital, Illumina, etc.
Where is 1Gene headquartered?
1Gene is headquartered in Hangzhou, China.
Which VCs invest in companies like 1Gene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at 1Gene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like 1Gene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.